Francesca Lim

机构：Advanced Cell Technology (United States), Hong Kong Polytechnic University, Singapore General Hospital, Columbia University Irving Medical Center, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, National Cancer Centre Singapore · ORCID：0000-0001-7194-2845

发表论文 112 篇 · 总被引 1135 次 · h-index 18

代表论文

• Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (2025 · Nature Cancer · 被引 52)
• Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia (2025 · Discover Oncology · 被引 6)
• Cell trajectory modulation: rapid microfluidic biophysical profiling of CAR T cell functional phenotypes (2025 · Nature Communications · 被引 5)
• Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion (2025 · International Journal of Molecular Sciences · 被引 3)
• The Cost-Effectiveness of Gastric Cancer Screening and Surveillance Among Average-Risk and Risk-Stratified Populations (2025 · Clinical Gastroenterology and Hepatology · 被引 2)
• Extracellular viral microRNAs as biomarkers of virus infection in human cells (2024 · Molecular Therapy — Nucleic Acids · 被引 2)